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EFFECT OF POTENTIAL COCHAPERONE MZB1 ON GRP94 
SUMMARY 
Grp94 is Hsp90 paralog, residing in endoplasmic reticulum (ER), implicated in 
efficient expression of various proteins secreted and presented on cell membrane. As 
an essential eukaryotic chaperone, a set of studies have already shown that Grp94 
involves in maturation of Toll-like receptors, integrin family members and antibody 
secretion. Since the condition of ER significantly differs from that of the cytosol, 
Grp94 must have been uniquely evolved from its cytosolic counterparts in order to 
deal with distinct client profile of ER. It is known that vast majority of Grp94 clients 
possess at least one disulphide bond whose formation is crucial to attain 3-D 
structure and stability for many ER proteins. Besides, ER is much more oxidizing 
than cytosol due to its enzymatic components catalysing disulphide formation. 
Despite of having same domain organisation with those of other Hsp90 family 
members, in which N terminal domain preceding M domain and finally C-terminal 
domain functioning in dimerization, Grp94 has significant conformational 
differences compared to its cytosolic counterparts. Most importantly, unlike other 
Hsp90, in the presence of AMP-PNP or ADP, Grp94 adopts same twisted V 
conformation which seems to make N-terminal dimerization unfavourable. It must be 
noted that binding of ATP makes Hsp90 family members undergo some 
conformational changes in which N- terminal domains of each protomer dimerize 
resulting in ATP hydrolysis. Furthermore, unlike its cytosolic counterparts, Grp94 
does not show different affinity profile for ATP and ADP. These data has been 
leading an intriguing question regarding to the extent in which Grp94 differs from its 
cytosolic homologs in undergoing conformational changes during its ATPase cycle. 
It is long standing enigma as to whether Grp94 is regulated by a co-chaperone which 
may mediate client loading or remodel ATPase cycle to function in maturation of a 
set of ER proteins. Even though some studies have shown that a set of protein 
interact Grp94 along with clues concerning physiological relevance, our current 
understanding of the precise nature of interaction in these presumptive proteins with 
Grp94 and their regulatory effects on Grp94 conformational changes are still infant. 
pERp1/MZB1 is relatively newly discovered protein residing in ER. Its function has 
not been fully understood, which presumably act as an unique oxidoreductase or 
chaperone. In previous studies, it has been demonstrated that pERp1 interacts with 
ER chaperones, Grp94 and BiP. In the context of this thesis, wild type Grp94 and a 
flanked at both terminal domains by partial ubiquitin version of Grp94 are compared 
by subjecting to ATPase assay and circular dichroism spectroscopy. The main aim is 
to check whether ubiquitin tagged Grp94 has no significant difference from wild type 
in ATPase kinetics and secondary structure. It must be noted that this version was 
important to do further investigation on Grp94 by single molecule study. Moreover, 
titration of pERp1 has been performed to calculate EC50 which is an indicator of 
binding affinity. Apart from steady state kinetics, citrate synthase aggregation assay 
and analytical size exclusion chromatography are applied to the respective proteins.  
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OLASI KOŞAPERON MZB1 PROTEİNİNİN GRP94 ŞAPERONU 
ÜZERİNDEKİ ETKİSİ 
ÖZET 
Glükoz regüle protein 94 (Grp94) ısı şok protein ailesinin üyesi olan Hsp90’ın 
endoplasmik retikulum (ER) paraloğudur. Birçok çalışmada Grp94 sekresyona  
uğrayan veya hücre membranında fonksiyon gösteren çeşitli proteinlerin efektif 
ekspresyonu ile ilişkilendirilmiştir. Grp94 ökaryotik hücreler için elzem bir 
şaperondur ve üzerine yapılan bazı fonksiyonel çalışmalar Grp94’ün Toll-like 
reseptörü, integrin ailesi gibi bazı proteinlerin son yapılarının kazanmasında ve 
antikor sekresyonunda rol aldığını göstermiştir. Endoplasmik retikulum organelinin 
protein içerik ve katlanma profili hücre sitozolüne oranla çok büyük farklılıklar 
göstermesi Grp94’ün farklı özellikler kazanarak evrimleşmiş olabileceğinin en 
önemli göstergesidir. Bu özellikler Grp94’ün otantik ER proteinlerin katlanma 
sürecinde rol oynamasını evrimsel süreç içerisinde önünü açmış olabilir. Örneğin, 
Grp94’ün müşteri proteinlerin dikkate değer en önemli farklılığı disülfid bağ(lar) 
içermeliridir.  
Hsp90 ailesindeki tüm homologlar aynı domain organizasyonuna sahiptir; sırasıyla 
N-terminal domain, orta domain (M) ve C-terminal domaindir. Grp94 de aynı 
domain sıralamasına sahip olmasına rağmen, kendine özgü konformasyona adapte 
olmuştur. Bu konformasyon literatürde ‘Kıvrılmış V Konformasyonu’ olarak 
adlandırılmış olup Hsp90 konformasyonunda katalitik aktivite ile ilişkilendirilmiş 
‘N-terminal domain dimerleşmesini’ mümkün kılmayacak niteliktedir. Nükleotid 
regüle olan Hsp90 ailesi ATP’nin bağlanmasıyla N-terminal domain dimerizasyonu 
ile başlayan büyük konformasyonal değişikliklere uğrar ve ardaşık konformasyonlar 
ATP’nin hidrolizi ve ADP’nin salınmasıyla sona erer. Bu veriler Grp94’ün ATPaz 
deviri sırasında hangi seviyede tanımlanan konformasyonlara adapte olduğunun 
irdelenmesine sebep olmaktadır. Grp94’ün ‘Kıvrılmış V Konformasyonu’ ATP 
aktivitesi için uygun olmamakla beraber, kristal yapısı (AMP-PNP ya da ADP) 
nükleotid kimliği ile değişmemiştir.  
Hsp90 şaperon protein ailesinin ATP ile tetiklenen konformasyonel deviri ATP’nin 
N-terminal domainde yer alan nükleotid bağlanma oyuğuna yerleşmesiyle başlar. 
Kapak görevi gören N-terminal yapı birimi ATP’nin üzerini kapatacak şekilde 
pozisyonlanması ile iki protomerin N-terminal domainleri dimerleşmesi tetiklenir. 
Bu konformasyonun dimerizasyonu daha sonra M domainin N-terminal domain ile 
temas kurmasına sebep olur ve ATP’nin kimyasal parçalanması vuku bulur. Daha 
sonra ADP ve Pi N-terminal domaini terk eder. Böylelikle Hsp90 tekrar yeni bir 
ATPaz devirine başlamaya hazır başlangıç konformasyonuna tekrar adapte olur. 
Grp94’ü diğer sitozolik Hsp90 üyelerinden ayıran bir diğer özelliği ATP’ye ve 
ADP’ye bağlanma eğiliminin aynı seviyede olmasıdır. Hem konformasyonel hem de 
bağlanma eğilimi açısından Grp94’ün ATP ve ADP’ye karşı profilinin değişmemesi 
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Grp94’ün ATPaz devirisi sırasında hangi düzeyde sitozolik Hsp90 üyelerinden 
farklılık gösterdiği sorusunun sorulmasına sepeb olmaktadır. 
Grp94’ün herhangi bir koşaperonun yardımı ile ATPaz devirinin regüle edilip 
edilmediği veya müşteri proteinleri ile etkileşime girmesinin sağlanıp sağlanmadığı 
uzun süren bir muammadır. Ayrıca, Grp94’ün birtakım potansiyel koşaperonlar ile 
etkileşime girdiği ve fizyolojik önemi açısından literatür bilgisi olmasına rağmen, 
müşteri proteinlerinin olgunlaşmasındaki fonksiyonu ve bu etkileşimin yapısal-
mekaniksel altyapısı hakkında herhangi bir ipucu şu ana kadar literatürde 
belirtilmemiştir. Potansiyel koşaperonların Grp94 üzerindeki etkisini araştıran 
üzerine şu anda kısıtlı bilgiler mevcuttur.  
Bu tezde potansiyel koşaperon olarak düşündüğümüz pERp/MZB1 proteini  kararlı 
hal kinetiği deneylerinde kullanılarak Grp94’ün ATPaz aktivitesine etkisi 
araştırılmışır. pERp1 nispeten yeni keşfedilmiş bir endoplazmik retikulum proteini 
olup hücre içindeki fonksiyonu tam olarak bilinmemektedir. Literatürdeki çalışmalar 
pERp1’in büyük olasılıkla özgün bir oksidoredüktaz ya da şaperon olduğunu ileri 
sürmektedir. Üzerine yapılan çalışmalardan bazıları pERp1’in BiP (Hsp70’in ER 
paraloğu) ve Grp94 gibi endoplazmik retikulum şaperolarıyla etkileşiğini ortaya 
koymuştur.  Ek olarak, önceki çalışmalar pERp1’in immünoglobin katlanmasında, 
hafif zincirlerin takımlaşmasında ve sekrasyonunda rol aldığıni göstermiştir. 
Tez kapsamında, yabanıl tip Grp94 ve hem N-terminal hem de C-terminal domain 
uçlarında kırpılmış ubikuitin eklenmiş, manipüle tip Grp94 (Ubi-Grp94-Ubi) ATPaz 
ve dairesel dikroizm spektroskopi deneyleri ile karşılaştırılmıştır. Bu deneylerdeki 
asıl amaç yabanıl ile manipüle edilmiş tip arasında kaydadeğer kinetik ve yapısal 
farklılıkların ortaya konmasıdır. Zira manipüle tipin (Ubi-Grp94-Ubi) 
klonlanmasının altında yatan sebep, yabanıl tipin içeriğinde bulunan 3 sistein amino 
asit molekülünün ‘tek molekül çalışmasında’ kullanılan, ticari florofor boyası Atto 
488 ile kimyasal tepkimeye girmemesidir. Kırpılmış ubikuitin proteinin kimyasal 
olarak tepkimeye girebilecek, yapısal anlamda açıkta 1 sisteini bulunmaktadır. 
Ayrıca, potansyel koşaperon pERp1 ATPaz deneylerine eklenerek Grp94 üzerindeki 
kinetik etkisi araştırılmıştır. Kararlı hal kinetiği çalışmaları içerisinde farklı pERp1 
konsantrasyonları Grp94’ün ATPaz aktivite deneylerine uygulanarak ‘Etkili 
Konsantrasyon (EK50)’ hesaplanmıştır. Hesaplanan EK50 değeri pERp1 Grp94 
arasındaki bağlanma eğilimi hakkında ilk bilgiyi ortaya koymuştur. Bu deneylerle 
pERp1’ın Grp94 ATPaz aktivitesini önemli ölçüde arttırdığı gösterilmiştir. Ek 
olarak, Ubi-Grp94-Ubi versiyonunun ATP’ye bağlanma eğilimi Km hesabıyla ortaya 
konulmuş ve literatürde önceden belirlenen yabanıl tip Km’si ile karşılaştırılmıştır. 
Deney sonucu manipüle tip Grp94’ün ATP’ye olan bağlanma eğiliminde düşüklük 
saptanmıştır. 
Şaperon proteinler normal büyüme koşullarında protein katlanmasını katalizlemesi 
yanı sıra termal stress gibi sert koşullarda hücre içerisinde proteinlerin yanlış 
katlanmasını ve kümeleşmesini önlemektedir. Hsp90 ailesi kendi müşteri 
proteinlerinin son olgunlaşma evresinde rol oynamaktadır ancak birçok şaperon ailesi 
gibi sert koşullar altında müşterisi olmayan proteinlerin stabilizasyonunda da rol 
almaktadır. Tez kapsamında, pERp1 ve Ubi-Grp94-Ubi proteinlerinin kümeleşmeye 
olan etkisi model protein sitrat sentaz kullanımıyla gerçekleştirilmiştir. Sitrat sentaz 
mitokondri matriksinde bulunan yüksek ısı koşullarında kümeleşmeye eğilimli bir 
enzimdir ve kümeleşme düzeyi spektroskopik yöntemlerle kolaylıkla takip 
edilebildiği için şaperon proteinlerin fonksiyonel çalışmaları için uygun bir modeldir. 
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Kinetik deneylere ek olarak, bu deney pERp1’in jenerik bir şaperon olmadığını 
aksine kümeleşmeyi hızlandırdığı ancak manipüle tip Grp94’ ün fonksiyonel 
anlamda etkin olduğunu göstermiştir. 
Önceki çalışmalar, pERp1 ve Grp94 etkileşiminin immünoglobin biyosentezi için 
önem taşıdığını ortaya koymuştur. Bu çalışmalarda Grp94-pERp1 etkilişimi ko-
immünopresipitasyon deneyleri ile açıklığa kavuşturulmuştur. Tez kapsamında, bu 
etkileşimin bir başka yöntem olan analitik jel filtrasyon deneyleri ile validasyonu 
amaçlanmıştır. Ayrıca bu teknik pERp1 proteininin oligomerizasyon karakterinin 
belirlenmesinde fikir vermiştir.  
Tez içeriği Grp94’ün olası bir koşaperon ile yapısal ve mekaniksel yaklaşımlar içeren 
bir projenin başlangıç aşaması niteliğindedir. Tez kapsamında önemli kinetik verilere 
erişilmiş olup pERp1’in Grp94 ATPaz devirinde etkili bir ajan olduğu saptanmıştır. 
Bu veriler çerçevesinde pERp1’in Grp94 konformasyonu üzerine genel senaryolar 
tartışma kısmında açıklanmaştır. Temel soruları açıklığa kavuşturacak etkileşimin 
yapısal analizi ve tek molekül çalışmaları Grp94 koşaperon muammasında temel 
tekniklerdir. 
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1. INTRODUCTION 
1.1 Protein Folding and Molecular Chaperones 
Protein folding is the process by which polypeptide sequences attain their unique 3-D 
structure. In the cellular environment, the adopted structures are required for the 
plethora of functions that proteins exert in the living cell. In 1972, Christian Anfinsen 
was awarded the Nobel Prize for discovering that protein folding is a spontaneous 
process which relies on the primary sequence of the polypeptide chain. The study 
was based on in vitro experiments which revealed that purified Ribonuclease A is 
refolded spontaneously without any additional factor assisting this process 
(Anfinsen, 1973). Attributed to this milestone discover, early on, it was thought that 
after the translation of a polypeptide, intramolecular interactions were sufficient to 
shape the unique 3-D structure. However, later, it was realised that, in many cases, 
protein folding in living organisms involves additional molecular machines which 
assist the folding process. These cellular components are called molecular 
chaperones and present a fundamental branch of the protein quality control network. 
Proteome integrity and proteostasis strictly depends on the chaperone network. In 
principle, chaperones function in preventing undesired intramolecular and 
intermolecular interactions, which result in misfolded states. Basically, chaperones 
ensure efficient protein folding in the cell.  
1.2 In Vivo Protein Folding and Chaperone Protein Concept 
In order to understand how the in vivo protein folding process differs from in vitro 
protein folding, the discrepancy between the conditions in the cellular environment 
and the test-tube must be taken into consideration. Most importantly, the cytosol 
contains high protein content with protein concentrations reaching up to 300 mg/ml 
in E. coli (Zimmerman & Trach, 1991). Compared to the test tube, the cytosol is a 
highly crowded milieu in which the folding process is dramatically influenced by 
macromolecular crowding. This is associated with an excluded volume effect and 
disturbs the entropic freedom of folding polypeptides (Ellis & Minton, 2006).  As a 
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result of the excluded volume effect, the intermolecular affinity constants are 
influenced, which enhances the susceptibility of cellular aggregation (Zimmerman & 
Minton, 1993). Moreover, the protein translation process increases the risk of 
misfolding and aggregation due to the emerging nascent polypeptide chain which is 
not acquired fully folded conformation. Proteins emerging from the exit channel of 
the ribosome need to either have been translated completely or at least as single 
domain in order to be folded to the native state (Deuerling & Bukau, 2004). In 
structural aspect, the ribosome exit channel is approximately 100 Å in length, but the 
diameter only allows a polypeptide to attain alpha-helix secondary structures. Thus, 
the emerging nascent chain is exposed to the crowded cytosol before folding process 
is completed by which polypeptide is stabilized by its native state (Ban et al., 2000; 
Lu & Deutsch, 2005).  The emerging nascent chain can adopt partially folded states 
and can become engaged in undesired intramolecular interactions. In such cases, 
propogation of misfolded state or even toxic aggregates can occur, consequently 
leading to a metabolic burden for cell.  To combat challenges of both co-translational 
and post-translational protein folding, living organisms have developed a diverse set 
of structurally unrelated molecular chaperones which assist cellular polypeptides to 
acquire their unique 3-D structures. Importantly, many members of the chaperone 
network belong to the heat-shock class and are upregulated under stress conditions 
(Vabulas et al., 2010). Under harsh circumstances, polypeptides in the cell are 
threatened to lose their unique structure, which disturbs the cellular protein 
homeostasis. In this case, the protection of the stability of proteins is highly 
important since conformational equilibrium of protein contents may dramatically 
shifts to non-native states which may result in loss of catalytically active 
conformation and raise of aggregation-prone conformers (Vabulas et al., 2010). Once 
the stress-denatured protein species are upregulated with high temperature or 
oxidative stress, a set of cellular agents called as ‘Heat Shock Protein (Hsp)’ are 
induced to create a network triggering protection as members of protein quality 
control mechanism. Therefore, primarily safeguard proteins, chaperones mainly are 
members of heat shock or stress-induced protein families (Vabulas et al., 2010). The 
function and cellular regulation of the chaperone network is thus, under both 
physiological and stress conditions, in the centre of protein folding. 
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Figure 1.1 :    Energy landscape representation of protein folding: The purple area represents 
the energy landscape of folding states originating from intramolecular 
interactions of a single polypeptide, such as partially folded states and the  
native state. The pink area depicts energy states of protein species arising 
from intermolecular interaction, in which possible states are amyloid fibrils, 
oligomers and amorphous aggregates (Hartl & Hayer-Hartl, 2009).  
 
Molecular chaperone protein is defined as any protein which either interacts and 
assists non-native conformers to fold into native conformation, or stabilizes to 
prevent undesired interactions (Hartl & Hayer-Hartl, 2009). These fundamental 
elements function in many cellular events, particularly de nova protein folding, 
refolding and disaggregation of off-pathway conformers and aggregates, polypeptide 
translocation into cellular compartments (Hartl et al., 2011). Over the course of 
evolution, chaperones have adapted to basically recognize hydrophobic motifs to 
protect the proteome from off-pathway which is navigated by undesired 
intramolecular and intermolecular interaction, rather than having steric information 
correspond to structure of the client (Hartl & Hayer-Hartl, 2009). A set of essential 
proteins such as tubulin and actin have strenuous folding pathway, consequently 
shows high dependence on chaperone proteins to deal with the challenge of their 
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trajectories which favourably last with non-native conformation and toxic 
aggregation (Hartl & Hayer-Hartl, 2009).   
Many structurally unrelated chaperone families serve as protectors of cellular protein 
integrity and homeostasis with their unique mode of actions (see table 1.1 and 1.2). 
Chaperones are mainly catagorized and named on basis of their molecular weights: 
small Hsp (sHsps), Hsp40, Hsp60, Hsp70, Hsp90 and Hsp100. Vast majority of 
chaperones are regulated by nucleotide, in which conformational cycle is associated 
with ATPase cycle. To illustrate, Hsp70 family is a ubiquitious chaperone machine 
which assists both co-translational and post-translational protein folding (Kim et al., 
2013). It is highly conserved from eubacteria to eukaryotes, interacting with 
substates in their unfolded, misfolded and aggregated states. In structural aspect, 
Hsp70 consists of two domains which are connected by a conserved hydrophobic 
linker. Hsp70 family involves in allosteric mechanism between nucleotide-binding 
domain (NBD) and substrate-binding doman (SBD) in which ATP binding into NBD 
regulates substrate interaction by increasing dissociation constant with decreasing 
affinity, and substrate binding into hydrophobic pocket of SBD triggers ATP 
hyrolysis (Mayer, 2013). Subsequent conformational changes take place with binding 
of substrate and nucelotide identity. Up to now, two conformations of Hsp70 has 
been illuminated, referred as ‘closed conformation’ and ‘open conformation’ on basis 
of lid proximity in respect of beta sandwich of SBD (Bertelsen et al., 2009; Kityk et 
al., 2012). The identity of nucleotide regulates respective conformations: ADP-bound 
Hsp70 adopts ‘closed’ whereas ATP-bound does ‘open’ conformations. Addition to 
nucleotide regulated conformational flexibity of Hsp70, two co-chaperone families J-
domain protein (JDPs) and nucleotide-exchange factor (NEFs), which function in 
synergism with Hsp70 increases the hydrolytic power of the Hsp70 by influencing 
energitical barrier between the two conformations. In basic, NEFs increases 
dissociation constant of ADP, JDPs transfer substrates to Hsp70 and regulate the 
ATPase activity (Mayer, 2013). In case of interaction with substrate, Hsp70 family 
binds a motif defined as 5 hydrophobic amino acids flanked by positively charged 
amino acids (Rudiger et al., 1997). What makes Hsp70 a versatile molecular 
chaperone is that the hydrophobic motif it interacts is present per 30-40 residues in 
almost any polypeptide of proteome. In the native conformation, this motif is 
positioned at the hydrophoic core and only exposed at the early stage of 
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Table 1.1 : Members of Hsp40, Hsp70 and Hsp90 (Chang et al., 2007). 
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potein folding or in denaturation conditions. The positional state of the motif in 
respect of folding process explains why Hsp70 interacts primarily with unfolded and 
misfolded proteins (Mayer, 2013). 
 
Figure 1.2 :  Conformational change of Hsp70 and the cyrstal structures in respect of ATP 
and ADP (Mayer, 2013). a) Allosteric mechanism involves nucleotide-driven 
two conformations in which ATP-bound open conformation makes substrate 
association and dissociation favorable with low affinity whereas ADP-bound 
has high affinity that dramatically decreases substrate dissociation. Substrate 
binding triggers ATP hydrolysis which causes conformational changes 
transmitted to SBD domain, lasting with closure of lid over the beta 
sandwich. b) ATP-bound open conformation (PDB ID: 4B9Q). c) ADP-
bound closed conformation (PDB ID: 2KHO).  
 
In contrast to Hsp70, in structure, chaperonins are chamber-like large oligomeric, 
double- ringed complexes which are divided into two groups: Group I (Hsp60, 
GroEL, in eubacteria) and Group II (Thermosome in archea, TRİC/CCT in 
eukaryotes) (Tang et al., 2007). Group I consists of one pair of ring, of which each 
has seven subunits and the assembly cooperates with cap-like co-chaperone, Hsp10 
whose structure is composed of one ring of seven subunits (GroES). Group II ring is 
made up of eight or nine subunits and lacks of  Hsp10 counterpart (Hartl & Hayer-
Hartl, 2009). One striking difference among the member of chaperonin family is that 
GroEL and the thermosome are in inducible character under heat stress whereas 
TRİC/CCT is not upregulated thermally (Horwich et al., 2007).  
GroEL has been reported to interact more than 250 proteins, of that 85 are obligated 
substrates which contains TIM barrel fold (Kerner et al., 2005). The structural basis 
of the interactions with such wide-range clients depends on the hydrophobic groove 
around opening face of the cavity which exhibits plasticity facilitating optimized 
interaction platform in respect of different clients.  Essentially, GroES serves as a lid 
for  encapsulation in processing of the clients. GroES  interaction with GroEL causes 
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Table 1.2 : Members of chaperonins, Hsp100, ribosome-associated chaperones and other chaperones (Tang et al., 2007). 
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dramatic structural changes in the cavity by which the hydrophobic residues are 
replaced by polar ones, basically. Thereby, the binding affinity for client critically 
decreases, and the client is unleashed in the cavity (Walter & Buchner, 2002). 
As in Hsp70 and Hsp90, GroEL is regulated by ATP binding and hydrolysis. The 
two rings asymmetrically function by which each is in different phases of cycle. 
There is positive cooperativity of ATP binding into each subunit (7 ATP per ring) for 
a ring. Conversely, between two rings negative cooperativity takes place, resulting in 
asymmetrical conformational changes in the ATPase cycle of the rings (Horwich et 
al., 2007). ATP-directed reaction cycle of GroEL-GroES complex is illustrated in 
Figure 1.3.  
 
Figure 1.3 :  Conformational cycle of the ATP-regulated GroEL-GroES: Asymmetric 
regulation takes place between the two rings in ATPase cycle (T denotes 
ATP-bound, D denotes ADP-bound rings). The ATP-bound ring accepts 
polypeptide substrate; subsequently the open face harbours the GroES. After 
encapsulation, the rigid body movements process releases polypeptide which 
may be in native (N), commited-intermediate (Ic) or uncommitted (Iuc) state. 
Concomitantly, the other ring binds ATP and polypeptide and new cis 
complex formed (Horwich et al., 2007).  
 
Protein quality control system serves not only in protein folding, macromolecular 
assembly but also disaggregation of intertwined non-native protein clusters and 
reliance of targeting potentially detrimental proteins to proteolytic pathway (Mogk et 
al., 2015). Upon harsh circumstances such as heat stress, aggregation susceptibilty is 
escalated critically due to increased non-specific intramolecular interaction. 
Hsp100/Clp is ATP-regulated hexameric chaperone family which serves as 
aggregation-solubilizer machine and component of protease complex, function based 
on principle of unfolding, belonging to AAA+ protein superfamily                
(Neuwald et al., 1999). Members of the superfamily share the same domain (AAA) 
which is about 230 amino acids in length, facilitating oligomerization and containing 
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conserved Walker A and Walker B motifs to bind and hydrolyse ATP. The members 
of Hsp100 family are divided on basis of the number of AAA domain per promoter, 
which may be one or two, and unique extra domain that gifts the member functional 
specifity in interaction with substrates (Mogk et al., 2015). 
 
Figure 1.4 :  Domain organisation and structure of Hsp100 family. a) Hsp100 family is 
classified in respect of variety in number of nucleotide binding domain 
(NBD). Class I includes one NBD whereas Class II has two NBDs. Each 
member may contain unique domain which plays role in substrate interaction 
and associated with specialized function (Doyle & Wickner, 2009). b) Crystal 
structures of T.thermophilus ClpB (PDB ID: 1QVR), E.coli ClpA (PDB ID: 
1KSF) and H.influenza HslU (PDB ID: 1E94). S.cerevisiae Hsp104 structure 
is based on Swiss-model, generated from T.thermophilus ClpB (PDB ID: 
1QVR) (Doyle & Wickner, 2009). c) Functional representation of bi-
chaperone complex (Doyle et al., 2013).  
 
Hsp104, also referred to as ClpB in E. coli is a member of Hsp100 chaperone family, 
specialized to reverse aggregation to counteract against stress conditions. The 
structure of Hsp104 is composed of N-terminal domain followed by nucleotide-
binding domain (NBD-1), a middle domain (M-domain) and another nucleotide-
binding domain (NBD-2), respectively (Lee et al., 2003). Both NBDs bind and 
10 
 
hydrolyse ATP. Oligomeric state is stabilized by ATP binding. However, the Hsp104 
mode of action in remodelling aggregates has not been fully understood (Doyle & 
Wickner, 2009). Regarding the function of ATP, it has been stated that ATP binding 
provides Hsp104 to adopt ‘holdase’ activity and subsequent hydrolysis changes the 
function to ‘unfoldase’ (Doyle et al., 2007). Same study has indicated that binding of 
slowly hydrolysed ATP analogue, ATP-γS provides remodelling for some substrates 
but does not account for some others which require the hydrolysis. Consequently, it 
has been suggested that the versatility in mechanism provided by each step, ATP 
binding and hydrolysis expands the repertoire of aggregated substrates which can be 
dealt with upon stress conditions (Doyle et al., 2007). Additionally, Hsp104 is not 
mere disaggregation machine, works in concert with Hsp70 and Hsp40 (JPDs). The 
complex is referred to as ‘bi-chaperone system’ by which the Hsp70 acts prior to 
Hsp104, controlling the recruitment of Hsp104 at the vicinity of aggregate clusters 
(Mogk et al., 2015). Hsp104-Hsp70 binding interface has been reported by a NMR 
spectroscopy, overlapping the binding interface of NEFs-Hsp70 which indicates that 
NEFs are not required in disaggregation process facilitated by Hsp70-Hsp104 
complex (Rosenzweig et al., 2013). Remarkably, the activation of Hsp104 requires 
more than one Hsp70 binding to Hsp104 (Mogk et al., 2015). 
ClpP is the first discovered member of Hsp100 as a component of the protease 
system (Fujimura et al., 1987). It is proteolytic central component of ATP-dependent 
protease system, and capped by a set of Clp members such as ClpA and ClpX to 
form ClpAP and ClpXP complexes, respectively (Doyle & Wickner, 2009). ClpP has 
been reported to bind both ClpA and ClpX simultaneously via its opposite sides to 
form active hybrid compex, ClpXAP (Ortega et al., 2004). This bi-functional 
protease system whose both ends harbouring different modulator is able to target 
different set of polypeptides independently (Ortega et al., 2004). 
There are diverse classes of chaperone families, of which each serves with unique 
mechanism, of some use catalytic power of the ATPase activity to drive different 
conformational states to deal with their authentic clients, and of some show 
oligomeric character. Addition to the families detailed above, the cell hosts many 
small heat shock (sHsp) families such as Hsp26 in S. cerevisiae and α-crystallin in 
mammalians, preventing and refolding the aggregation in concert with other ATP-
dependent chaperones (Bakthisaran et al., 2015). 
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1.3. The Chaperone Hsp90 
Hsp90 is a conserved and abundant molecular chaperone that regulates the final 
maturation and activity of various clients which mainly function in cellular stress 
response, proliferation and hormone signalling (Young et al., 2001; Wandinger et al., 
2008). Some of these clients are implicated in cancer progression, which makes 
Hsp90 a potential target for therapeutic approaches (Solit & Rosen, 2006). Hsp90 is 
an essential protein in eukaryotes whereas the prokaryotic homologue of Hsp90, 
HtpG, is dispensable. In some cellular compartments Hsp90 paralogues are present: 
In the ER, the paralogue is called Grp94 and in mitochondria Trap1.  
Hsp90 interacts with more than 200 clients (Li et al. 2012). In contrast to other 
chaperones, Hsp90 binds its clients without having a preference for specific 
structures. The molecular basis of client recognition of Hsp90 is largely unknown 
(Karagöz & Rudiger, 2015). Next to largely folded clients, Hsp90 has been reported 
to interact with partially folded and intrinsically disordered clients such as p53 and 
Tau, respectively (Karagöz & Rudiger, 2015).  
More than 20 co-chaperones exert a regulatory influence on Hsp90 by facilitating 
client-loading conformation, the recruitment of clients and modulation of the ATPase 
cycle. The cooperation with various co-chaperones enables Hsp90 to be a rather 
versatile chaperone dealing with structurally diverse clients (Röhl et al., 2013).  Even 
though many aspects of co-chaperone effect on Hsp90 as in asymmetric complex 
have not been clarified yet, the ordered progression in co-chaperone interaction has 
been implicated in maturation of certain clients (Röhl et al., 2013). 
1.3.1 Structure and conformational change of the Hsp90 
Hsp90 exerts its cellular functions as obligate homodimer of which each protomer 
consists of three domains. The N-terminal domain has a molecular weight of 
approximately 25 kDa and contains a binding pocket for ATP. Various drugs have 
been developed that bind in this pocket (Solit & Rosen, 2006). A charged linker at 
the boundary between N-terminal and middle domain is implicated in regulation of 
Hsp90 (Tsutsumi et al., 2012). The middle domain (referred to as M domain) is 
known as to interact with various clients and co-chaperones (Karagoz & Rudiger, 
2015). The most important function of the C-terminal domain is to mediate the 
dimerization of the two protomers (Li et al., 2012). Hsp90 is a member of the GHKL 
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ATPase family, members of which share a similar ATP binding pocket (Dutta et al., 
2000).  Even though the domain organisation is highly conserved among the Hsp90 
homologues (Figure 2), each homologue has differences in sequence and structure. 
These differences are tightly associated with the unique functional properties of each 
homologue (Johnson, 2012). 
 
 
   Figure 1.5 :  Domain organisation of  the  Hsp90  homologues. The N-domain                                                                     
             is coloured in blue, the M-domain in green and the C-domain in brown               
  (Krukenberg et al., 2011). 
 
Hsp90 shows an ATP-dependent chaperone function and its ATPase activity plays a 
crucial role for viability in yeast. It is reported that the ATPase activity is essential 
for maturation of hormone receptors and kinases (Panaretou et al., 1998). Both 
structural and biophysical studies revealed that Hsp90 adopts a set of structurally 
distinct conformations driven by nucleotide identity and ATP hydrolysis (Ali et al., 
2006; Shiau et al., 2006; Hessling et al., 2009; Mickler et al., 2009). In the absence of 
nucleotide, Hsp90 adopts an open V-shaped conformation which exhibits a large 
solvent exposed surface.  Binding of ATP to the pocket in the N-domain makes the 
lid closure favourable and causes the formation of the first intermediate state. 
Subsequent structural arrangements lead to the closed conformation, in which the N-
domains of each protomer dimerizes and contacts between N and M domain are 
facilitated, resulting in hydrolysis of bound ATP. It should be noted that Hsp90 
family is higly dynamic and able to adopt all cycle conformations in the absence of 
nucleotide. In other words, nucleotide does not dictate a certain conformation 
(Southworth et al., 2008; Krukenberg et al., 2009; Mickler et al., 2009).  
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Figure 1.6 :  The ATPase cycle of  Hsp90: The cycle begins with the binding of ATP into 
the nucleotide binding pocket of the N-domain with diffusion-collision effect. 
The lid closes over the ATP and Hsp90 adopts the first intermediate state (I1). 
The second intermediate state (I2) is formed by N-domain dimerization. 
Subsequent rearrangements drive Hsp90 into a more compact closed state, in 
which N- and M- domains contact, which makes ATP hydrolysis favourable. 
After release of ADP and Pİ, the cycle ends and Hsp90 adopts the open state 
and the cycle begins again (Li & Buchner, 2013). 
 
The ATPase activity of Hsp90 is slower than those of many other ATP-dependent 
chaperone proteins. Yeast Hsp90 hydrolyses about one ATP molecule per minute, 
whereas the human homologue is approximately ten times slower (Panaretou et al., 
1998; Richter et al., 2008). Concerning the human Hsp90, the possible reasons 
behind the weak ATPase rate have been proposed to be caused from either its distinct 
conformational equlibrium or rate of hydrolysis and ADP dissociation. Additionally, 
the kinetic data which have been presented up to now showed that the rate limiting 
step of human Hsp90 is the chemical breakage of ATP rather than dissociation of 
ADP. Regarding the relevance among the cycle elements, while the ATPase activity 
of the Hsp90 is essential for its function in client maturation, along with various co-
chaperones the client binding regulates ATPase cycle of Hsp90 (McLaughlin et al., 
2004). The extent to which concert of the client, co-chaperone and Hsp90 triad is 
associated with ATPase cycle is under investigation of current studies. 
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1.3.2 The endoplasmic reticulum paralogue of Hsp90, Grp94  
Grp94, also known as gp96 or endoplasmin, is an essential chaperone protein which 
is expressed ubiquitously in the ER. It is required for the maturation of various 
secretory and membrane proteins. The clients of Grp94 are implicated in signal 
transduction and immune response (Pratt & Toft, 2003; Pearl & Prodromou, 2006). 
A set of clients associated with the immune system has been reported, including 
IgGs, integrins and Toll-like receptors (Melnick et al., 1994; Randow & Seed, 2001; 
Yang et al., 2007). Most importantly, Grp94 plays a role in the development of 
metazoans and it is not present in unicellular organisms (Eletto et al., 2010). 
However, Grp94 knock-down in mammalian cell culture leads to slow growth 
without deficiency in surface receptor expression and differentiation (Ostrovsky et 
al., 2009; Wanderling et al., 2007; Randow & Seed, 2001).  
Unlike its cytoplasmic counterparts, Grp94 is able to bind calcium (Biswas et al., 
2007). Grp94 seems to bind between 16 and 28 Ca
2+
 molecules (Macer et al., 1988; 
Van et al., 1989) and over-expression of it is reported to compensate the toxic effect 
of a  high  intracellular Ca
2+
 concentration (Vitadello et al., 2003). 
Since the ER differs from the cytosol, Grp94 must have evolved to deal with a 
different client spectrum. The first identified clients of Grp94 were intermediates of 
the immunoglobin family, which also interacts with the ER chaperone BiP in a 
sequential manner (Melnick et al., 1994). Furthermore, it has been reported that the 
maturation of insulin-like proteins, IGF-1 and IGF-2 are dependent on Grp94 
(Ostrovsky et al., 2009). Although it has long been an enigma whether Grp94 has a 
bona fide ATPase activity, a set of studies has proposed a role of ATP hydrolysis in 
client maturation. Mutation of either the putative catalytic residue E103 or the ATP-
binding residue D149 abolishes Toll-like receptor expression while these mutations 
have no effect on integrin expression (Randow & Seed, 2001). However, later, an 
accessory protein was reported to be a potential co-chaperone of Grp94 and 
implicated in proper expression of Toll-like receptors. Since the putative catalytic 
residue E103 is indispensable for interaction with this suspected co-chaperone, the 
co-chaperone interaction rather than the ATPase activity might be decisive in the 
maturation of Toll-like receptors.  
15 
 
It has been clarified by two independent studies that Grp94 has an intrinsic ATPase 
activity (Frey et al., 2007; Dollins et al., 2007). In one study the kinetic parameters of 
Grp94 were elucidated, and it was reported that the ATPase rate of Grp94 is 
comparable to that of the yeast counterpart, Kcat=0.36 min
-1
. The same study also 
showed that Grp94 binds tighter to nucleotides than the other Hsp90 family members 
(Frey et al., 2007). Another study has given structural insights of nucleotide-bound 
Grp94 (Dollins et al., 2007). The study also includes a measurement of the ATPase 
rate of Grp94 and chimeric constructs in which the three domains are swapped 
between Grp94 and cytosolic yeast Hsp90. In this study, the ATPase rate is assessed 
as yielding Kcat=0.02 min
-1, unlike the rate determined in Frey’s article. Besides, the 
ATPase rates of the chimeric constructs suggest that the difference in the ATPase 
rate between Grp94 and yeast Hs90 mainly arise from the N-domain (Dollins et al., 
2007).  
Dollins’ paper has great importance since has disclosed the first crystal data of ADP- 
and AMP-PNP-bound full-length Grp94 at 2.4 Å resolution. Interestingly, this study 
shows that there is no significant difference between AMP-PNP- and ADP-bound 
Grp94, which both adopted to the twisted V conformation reminiscent of an 
intermediate between apo HtpG and AMP-PNP-bound yeast Hsp90 crystal 
structures. Intriguingly, in the crystal data, the putative catalytic residue from M-
domain, R488 is positioned more than 21 Å away from the γ-phosphate of the bound 
AMP-PNP, which seems to have distant proximity for interaction. For proper 
alignment of the putative catalytic residues, it appears that the M-domain would need 
to swing 90
o
 towards the nucleotide. The study thus points out that either clients or a 
co-chaperone may play central role in triggering ATP hydrolysis (Dollins et al., 
2007).  
The effect of nucleotide binding on the conformation of Grp94 has been investigated 
extensively with various techniques including SAXS, EM, co-crystallization and 
biochemical experiments (Dollins et al., 2007; Frey et al., 2007; Immormino et al., 
2004; Krukenberg et al., 2009; Soldano et al., 2003). A SAXS study has shown that 
in solution, the spectrum of Grp94 conformations resembles that of Hsc82 and Hsp90 
α (Krukenberg et al., 2009). Notably, the same study reported that addition of 
nucleotide cause a slight shift to the closed conformation of Grp94, which does not 
reach the extent of inducable form of cytosolic yeast counterpart, Hsp82 
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(Krukenberg et al., 2009). Unsuprisingly, among the different members of Hsp90 
family, the level of the shifts to the closed conformation are correlated with the ATP 
hydrolysis powers. 
 
Figure 1.7 :  Structural comparison of mamalian Grp94, yeast Hsp90 and bacterial HtpG. 
a) Crystal structure of AMP-PNP bound canine Grp94, the closed state of 
yeast Hsp90 and the apo form of HtpG. B) N-domain structural alignment of 
AMP-PNP- bound Grp94 (blue) and AMP-PNP-bound conformation of yeast 
Hsp90 (green). C) The positioning of putative catalytic residues of AMP-
PNP bound Grp94 (blue) and yeast Hsp90 (green). R448 residue of Grp94 
seems to have relatively much distance than do its cytosolic counterpart 
(Dollins et al., 2007).  
 
Aid to the structural explanation of the ATPase activity of the mamalian Grp94 and 
discovering an unseen twisted conformation, the structure also revealed a potential 
client-binding site positioned in an alpha-helix, composed of central Methionine (M-
M, residues 658 and 662) pair and four solvent-expose aromatic residues (Y652, 
Y654, Y677 and Y678). The role of binding of the client or any unexplored co-
chaperone has been proposed to be triggering factor that enables Grp94 exceeds 
transition energy barrier for N- terminal dimerization. Although for cytosolic yeast 
Hsp90, it has been earlier elucidated that the same conserved binding platform takes 
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a part in interaction with glucocorticoid, its role in Grp94 is still unknown (Dollins et 
al., 2007).  
1.4 pERp1/MZB1 
Perp1, also called as MZB1 is novel lymphocyte-specific 18 kDa ER protein which 
is implicated in immunoglobin folding, assembly and secretion. (Shimizu et al.,2009; 
Anken et al., 2009). Knock-down and upregulation assays revealed that pERp1 is a 
essential folding factor for IgM, which may act as unique oxidoreductase or co-
chaperone of BiP complex (Anken et al., 2009; Rosenbaum et al., 2014).  
During differentiation of the B cell to plasma cell, a set of striking morphological 
changes occur and the B cell is adapted to produce large amount of antibody (Anken 
et al., 2009). To demand daily antibody secretion as high as its own mass, ER is 
expanded accompanied by upregulation of protein quality control and proteolysis 
components. Producing antibodies in the ER needs to be processed by oxidative 
folding and accurately assembled to gain native structure and function. Protein 
disulfide isomerase (PDI), ERp57 and oxidoreductases are upregulated to support 
formation, reduction and isomerization of intra- and inter-chain disulfide bonds, 
effectively (Wiest et al., 1990; Anken et al., 2003; Shaffer et al., 2004). Concert 
among these components with significant increase in their quantity plays crucial role 
in differentiation of B cell becoming antibody secretion machinery. pERp1 is newly 
discovered protein which is upregulated over the course of B cell differentiation, 
reaching the extent as much as BiP in amount (Anken et al., 2009). The precise mode 
of pERp1’s action is still elusive.  
pERp1 is highly expressed in spleen relative to other tissues. It includes 6 cysteines 
in total and CXXC motif which is hallmark of oxidoreductases. In vitro thiol-
reductase activity assay revealed that pERp1 has modest oxidoreductase activity. In 
addition, pulse-chase and mass spectrometry analyses discovered that CXXC 
interacts another motif C(X)6C, forms long-range intrachain disulfide bond which 
seemingly stabilizes overall structure (Anken et al., 2009). PERp1 interacts with both 
heavy and light chain of the IgM both covalently and noncovalently (Shimizu et al., 
2009). Since pERp1 is able to bind IgM monomers noncovalently, it is proposed that 
pERp1 may function as molecular chaperone. According to other scenario, pERp1 
may display greater oxidoreductase activity in the condition of ER compared to in 
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vitro and may be a cell-line specific oxidoreductase which differs from other known 
ones (Anken et al., 2009). 
   
 
Figure 1.8 :  Sequence and structure of the pERp1. a) Amino acid sequence of Mus 
musculus pERp1. Italic sequence is target sequence.  6 conserved cysteines 
are with asterisks, and CXXC motif is in bold. Underlined sequences convey 
mass spectrometry obtained polypeptides. Double underlined ‘REEL’ is 
retention sequence (Shimizu et al., 2009). b) Representation of disulfide 
bonded structure of pERp1 (Anken et al., 2009). 
 
It has been long known that Grp94 serves as chaperone of IgM light chain by which 
the interaction followed by that of Hsp70 member, BİP (Binding Immunoglobin 
Protein) in a sequential manner (Melnick et al., 1994). The same study has disclosed 
that the immunoglobin light chain binding to Grp94 has distinct characteristics 
compared to BİP, respecting life-time of interaction and oxidation state of the clients. 
Remarkably, Grp94 binds the oxidized immunoglobin intermediates with relatively 
longer-standing time course with regard to BİP which binds early intermediates 
promiscously. The authors highlight within a remark which claims that Grp94 assists 
the maturation of immunoglobins with more advanced action and mostly function as 
an assembler of the chains (Melnick et al., 1994). Another study which is more 
latterly published, showed that Grp94 is strictly dependent on pERp1 for the 
maturation of the mHC in ER stress condition stimulated by tunicamycin. The study 
mainly revealed that the interplay between pERp1 and Grp94 is essential for the 
fidelity of immunoglobin assembly and secretion. This data brings along with a 
rising question as to whether it is co-chaperone of ER Hsp90, Grp94 (Rosenbaum et 
al., 2014). However, there is not enough study which has examined it in aspects of 
molecular structure and biophysics. 
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1.5 Aim of the Study   
In the context of study, it is aimed to shed light on long standing elusive point of 
Grp94 as to whether Grp94 is regulated by a co-chaperone influencing the ATPase 
cycle. In a set of previous studies, Grp94 has been shown to interact with 
immunoglobin intermediates (Melnick et al., 1994). Similarly, pERp1 seems to play 
a central role in immunoglobin maturation, assembly and secretation (Shimizu et 
al.,2009; Anken et al., 2009). Hereby, the question regarding if these two 
components of ER are in concert to deal with immunoglobin folding rises to be 
answered with molecular mechanistic details. 
In this thesis, an initial step has been taken by steady state kinetics of Canis lupus 
Grp94 conducted with Mus musculus pERp1 in order to discover further implications 
of interaction and regulatory effect of pERp1 on Grp94. Besides, a truncated 
ubiquitin-tagged Grp94 is constructed in order to be used in single molecule studies 
since wt Grp94 is not compatible to be stained by Atto 488 dye. Possible 
concequences resulted from tagging of Grp94 with truncated ubiquitin were 
investigated by regenerative ATPase assay with determining Kcat and Km and circular 
dichorism techniques.  
In order to show binding of pERp1 and Grp94, analytical size exclusion 
chromatography is operated with Superdex 200  10/300 GL column connected to 
HPLC system. This technique may let us check the possible oligomeric state of 
pERp1, even might open the way of using it in line with light scattering (SEC-
MALS) to determine steochiometry of binding. Furthermore, it is aimed to perform 
aggregation assay by which a model temperature-reacted protein, citrate synthase has 
been used and whose aggregation state monitored by increase in absorbance at 360 
nm. Possible effect of pERp1 itself and in combination with tagged Grp94 on 
aggregation let us make new inferences would be very indicative for investigation of 
further details.  
All in all, steady state kinetics of wt Grp94, Ubi-Grp94-Ubi and combination of each 
with potential co-chaperone pERp1/MZB1 gave us first insight on Grp94 mode of 
action. Possible effect of pERp1 on kinetics of Grp94 might be sign of specific client 
loading conformation of Grp94 which is attained with the interaction. Furthermore, 
binding kinetic of pERp1 and Grp94 has been calculated by titration of pERp1 via 
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steady state ATPase activity measurements. The study is crucial to clarify the 
existence of a co-chaperone of Grp94 which has not been discovered yet. Since there 
is not a structural insight of the interaction presented in this thesis, the results can be 
considered as initial step of a project concerning indeterminate chaperone cycle of 
Grp94 and implication of pERp1-regulated maturation of immunoglobins by Grp94. 
 
 
Figure 1.9 :  Structure of Grp94. a) Twisted V conformation which is favourable  in the 
presence of nucleotide (PDB ID: 2O1V). b) Nucleotide-bound N terminal 
domain of Grp94 (Eletto D., 2010). c) Extended chair-like conformation in 
solution (Krukenberg , 2009). 
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2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Laboratory equipments  
Laboratory equipments are shown in the Appendix A.  
2.1.2 Chemicals and enzymes  
Chemicals and enzymes used in the experiments are given in the Appendix B.  
2.1.3 Buffers and solutions  
Buffer and solution used in the experiments are given in the Appendix C.  
2.1.4 Commercial kits 
Commercial kits and used in the experiments are given in the Table 2.1.  
                          Table 2.1: Commercial kits used in the experiments.  
Kit Sequence 
Wizard
R
 PCR Clean-up Kit Promega 
Wizard
R
 Miniprep Kit Promega 
T4 Polymerase New England BioLabs 
1 kb DNA Ladder Peqlab 
Low-range SDS Marker Biorad 
High-range SDS Marker Peqlab 
 
2.1.5 Bacterial strains 
E. coli Mach1 strain was used for plasmid amplification and BL21 DE3-
CodonPlus™-RIL was transformed by respective plasmids in expression of both 
Grp94 constructs and pERp1. XL-1 Blue was transformed by one step sequence and 
ligation-independent cloning (SLIC) mixture at the last step. 
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2.2 Methods 
2.2.1 Subcloning of Grp94  
pET-21a plasmid including wt Grp94 was used in transformation of E.coli XL-1 
Blue competent cells. 1 µL (approximately 90 ng) plasmid DNA was added to 50 µL 
competent cells taken from -80 
o
C. Then, plasmid - competent cell mixture was taken 
on ice for 30 minutes. Heat shock was applied at 42
 o
C for 45 seconds and the 
mixture was incubated on ice for 2 minutes. After these steps, 1 ml LB was added to 
mixture and incubated at 37 
o
C for 1 hour in shaker. Finally, the mixture was spread 
on ampicilin including LB plate (100 mg/L). The plate was incubated at 37 
o
C for 16 
hours. As final step, a single colony on plate was inoculated into 5 ml LB and after 
overnight incubation at 37 
o
C plasmid purification was performed by protocol of 
Promega Miniprep Kit
R
.  
wt Grp94 gene of interest was amplified from pET-21a by PCR. Used primers were 
designed as being compatible with one step sequence and ligation-independent 
cloning (SLIC) protocol (Table 2.2).  
 
Table 2.2: PCR primers compatible with SLIC. 
Primers 
(Homology with Pet28a vector) 
Sequence 
Forward Primer (16 bp) GAGAGGTGGTGAGCTCgacgatgaagtcgatgtg 
Reverse Primer (18 bp) GAAGATCTGCATAAGCTTtaattcatctttttcagctgtag 
  
 
pET-28a including ubuquitin-tagged Hsp82 purified by using identical approach. 
Purified pET-28a  plasmid double digested by SacI and HindIII in order to eleminate 
Hsp82 presesent in the plasmid, run on 1% agarose gel afterwards. Respective part of 
gel was cut and restricted pET-28a was taken out, subsequently cleaned up to 
perform SLIC cloning with Grp94 PCR product. SLIC mixture was introduced with 
XL-1 Blue strain and transformation was performed as explained previously.  
SLIC method mainly depends on preparation of insert gene with 15 bp or more 
extension homologous to each flank of linearized vector. Linearization of vector can 
be performed by either restriction enzymes or inverse PCR.  Linearized vector and 
insert gene are incubated 2.5 min accompanied by T4 polymerase which function as 
generator of elongation of 5’ overhangs. It is a cloning method highly comparable to 
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other methods including ligation-dependent  cloning methods in terms of efficiency, 
economy of time and usability (For the protocol see Table 2.3). It is highly 
compatible for high-throughput genomic studies (Jeong et al., 2012). 
                       
  
 
Figure 2.1 :  Overview of one-step SLIC. a) Steps in SLIC method: Firstly, the vector 
aimed to be introduced by interested gene is linearized by enzymatic 
digestion or inverse PCR. Insert gene is prepared as to have at least 15 bp 
homology with the vector. Processed vector and insert are mixed and T4 
polymerase is treated with additional components. After 10 minutes, bacterial 
transformation is carried out. b) Annealed parts of vector and insert gene with 
overhangs. Homologous segments have same colour (Jeong et al., 2012).  
 
                                 
                                    Table 2.3: PCR and SLIC protocols. 
PCR SLIC 
1 µl Template (pET-21a) 50 ng Digested Vector (pET-28a) 
1 µl Primer (Each) 1:8 Molar Excess of PCR Insert (Grp94) 
5 µl 10x Pfu Buffer 1 µl NEB2 Buffer 
39.5 µl H20 1 µ 10x NEB BSA 
1.5 µl dNTPs (10 µM each) 0.4 µl NEB T4 Polymerase 
1 µl Pfu Polymerase H2O adjusted to 10 µl final volume 
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2.2.2 Plasmid transformation  
The pET-28a including Ubi-Grp94-Ubi and pET-21a-Grp94 were transformed into 
E. coli BL21 DE3-CodonPlus™-RIL cell strain by similar transformation protocol as 
in that of XL-1 Blue transformation that was explained in 2.2.1. Unlike pET-21a, 
pET-28a has resistance against kanamycin. 
2.2.3 Expression of wt Grp94, Ubi-Grp94-Ubi and pERp1  
After the transformation, E.coli BL21 DE3-CodonPlus™-RIL cells, taken from one 
colony, were incubated at 37 
0
C for 16 hours in 50 mL LB medium containing 
ampicillin for wt Grp94 containing pET21-a or kanamycin for Ubi-Grp94-Ubi 
containing pET-28a. After 16 hours, 15 mL of growth was appended into 4L LB 
including respective antibiotics. Then, the culture was incubated at 37 
0
C until 
OD600=0.8. Once OD reached 0.8, 1 mM IPTG was added to medium for induction. 
Before addition of IPTG, 1 mL sample was taken to eppendorf as a negative control. 
After 3-4 hours growth, cells were centrifuged at 6000 rpm for 30 minutes. Later, 
supernatant was discarded and cells were resuspended with resuspension buffer. 
Finally, resuspended cells were stored at -20 
0
C.  
pET-32a including Trx-Tag_pERp1 sequence was used for transformation. Induction 
was carried with addition of 0.5 mM IPTG as final concentration when OD reached 
0.5. The growth was incubated at 37 
0
C for 16 hours. 
2.2.4 SDS-PAGE  
To perform SDS-PAGE in order to check induction and purification level, 15 % and 
10 % separation gels were used for pERp1 and Grp94 constructs, respectively. After 
electphoresis process, gels were stained by comassie blue solution, Fairbank A (15 
minutes incubation after boiling) and destained by Fairbank D (5 minutes incubation 
after boiling).  
Content of the  SDS-gels is shown in Appendix  C. 
2.2.5 Disruption of the cells   
French press as a physical method was carried out to disrupt cells. Before the process 
MixG protease inhibitor cocktail and after 0,2 mM PMSF was added as final 
concentration.     
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2.2.6 Purification of Grp94, Ubi-Grp94-Ubi and pERp1  
Protein purification was operated by fast protein liquid chromatography (FPLC). 
Three different separation steps were performed to achieve purified proteins. For wt 
Grp94, as a first step Q Sepherose
TM
 column was used in which washing was 
operated by Buffer A and elution by Buffer B. Collected elution was dialysed against 
Solution A to be loaded onto Resource Q
TM
 column in which gradient approach was 
operated into the fractions. As a final step, gel filtration chromatography (Hi-load 
200pg GE Healthcare column) was performed with Buffer C.  
Concerning Ubi-Grp94-Ubi, as a first step Ni-NTA  HisTrap
FF
 column was used 
since the construct contain His-tag in the truncated ubiquitin tag positioned at C-
terminal. Washing phase was carried out by Phosphate Buffer A, elution was 
collected with Phosphate Buffer B. Respective elution fractions were pooled and 
dialyzed against Buffer A, subsequently loaded onto Resource Q
TM
 column. With 
same protocol followed in purification of wt Grp94, the gel filtration 
chromatography (200pg GE Healthcare column) was applied to the elution.  
pERp1 purification was started with IMAC by using HisTrap
FF
 with Phosphate 
Buffer A in washing and Phosphate Buffer B in elution as described for Ubi-Grp94-
Ubi. Dialysis against Tris Buffer A is performed in order to polish the imidazole off. 
Subsequently, elution was loaded onto Resource Q
TM
 and FPLC was operated with 
Tris Buffer A and B. Gel filtration chromatography was performed by 75pg GE 
Healthcare column along with Tris Buffer A. Collected fractions were pooled, 
concentrated and subsequently dialyzed against Phosphate Buffer A. To separate 
TRX-Tag, TEV Protease was appended into pERp1 and incubated for overnight at 4 
0
C. One more HisTrap
FF
 was performed to get rid of His-tag including TRX-Tag. 
pERp1 is collected from flowthrough and dialysed against TRIS Storage buffer. 
2.2.7 ATPase activity assay 
ATPase activities of Grp94 constructs were measured by real-time monitoring of 
oxidation of NADH to NAD
+
. Hydrolysis of ATP to ADP converts 
phosphoenolpyruvate (PEP) to pyruvate by catalyzation of pyruvate kinase (PK). 
Lactate dehydrogenase (LDL) converts pyruvate to lactate by converting NADH to 
NAD
+
. Oxidation of NADH to NAD
+
 is proportional to ATP hydrolysis. ATPase 
activity can be observed by tracking decrease of NADH with extinction coefficiency 
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6200 cm
-1
M
-1
 at 340 nm by Cary UV Visible spectrophotometer.  The reaction was 
carried out in 150 µL reaction mixture, containing ATPase buffer (40 mM 
HEPES/KOH, 150 mM KCl, 5 mM MgCl2, 2 mM ATP, 1.02 mM PEP, 0.2 mM β-
NADH, PK/LDH cocktail (9.94 U/mL PK-14.2 U/mL LDH), 3µM Grp94 protein. 
pH was adjusted to 7.5 and the each reaction took place at 30 
0
C. ATPase activity 
was calculated with following equation: 
          ATPase rate [min
-1
] = - dA340/dt [OD/min] x K
-1
path x moles
-1
 ATPase  
As negative control, the competitive inhibitor of Grp94, 20 µM NECA was used and 
unspecific ATPase activity resulted from contamination was subtracted from the 
value of measurement without NECA. 3 independent measurements were performed 
for each experiment.  
pERp1 and Grp94 constructs were incubated 15 mins together in ATPase buffer 
before the mixture was introduced to ATP. Additionally, to determine Km value of 
Ubi-Grp94-Ubi same protocol has been used with measurements of ATPase activity 
in different concentration of ATP at 37 
0
C. Kcat values are fitted in respect of 
Michaelis Menten equation.  
EC50 (Half maximal of effective concentration) is expected to be in good line with Kd 
value of pERp1 and Ubi-Grp94-Ubi has been evaluated titration of pERp1 into Ubi-
Grp94-Ubi ATPase activity at 30 
0
C. 3 independent measurements are performed and 
mean values of Kcat were used and fitted to Michaelis Menten equation. It should be 
noted that first 10 minutes is taken into account to determine Kcat values in titration 
of pERp1. 
2.2.8 Circular dichroism measurement  
Circular Dichroism (CD) is a spectroscopy technique, based on scattering right and 
left handed polarized light which is absorbed by interested matter, outputting 
different intensity. Far UV CD studies gives clues about the secondary structure of 
proteins whereas near UV reveals fingerprint of tertiary structure since the number 
and solvent expose state of aromatic amino acids differ protein to protein. CD is 
versatile tool to investigate secondary structures of manipulated versions of a certain 
protein roughly to be compared with wild type.  
In the context of this thesis, far UV CD studies were performed by Jasco-715 
spectropolarimeter. Measurements were carried out at 20 
0
C in 0.2 cm cuvette. The 
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signals collected from 195 nm to 260 nm with 1 nm band width and 8 seconds 
integration time. Both constructs were dialyzed against 20 mM Hepes, 75 mM KCl, 
pH 7.5  before the measurements. 
2.2.9 Citrate synthase aggregation assay  
Citrate Synthase (CS) is a model protein which is aggregation prone in high 
temperature. What makes it convenient is that its aggregation progression can be 
simply monitored by both light scattering and absorbance at 360 nm. Molecular 
chaperones known as aggregation supressing component of cell. Even CS is not 
authentic client, Grp94 has versatile function in interacting with unstable proteins to 
keep them functional. 
In this thesis, the effect of Grp94, pERp1 and their combination to aggregation of CS 
has been monitored by spectrophotometer at 360 nm. The temperature of system was 
adjusted to 43 
0
C which has been optimized and reported in literature (Buchner et al., 
1991). 0.3 µM CS conducted to 1 µM Grp94 and 5 µM pERp1 both independently 
and in together. Reactions took place in Hepes Buffer (pH 7.5) with 150 µl volume 
and monitored by 50 minutes. 
2.2.10 Analytical size exclusion chromatography 
In order to show possible interaction of pERp1 and Grp94, analytical size exclusion 
(Superdex 200 10/300 GL) with HPLC system operated. Size exclusion 
chromatography works with the simple principle of that the proteins which have 
different molecular weight have different hydrodynamic volume. Each protein 
migrated with different rates in designed columns since high molecular weight 
protein or protein complexes relatively moves fast compared to the low molecular 
size proteins.  
In our study, pERp1 and Grp94 has been independently subjected to Superdex 200 
10/300 GL column in which buffer including 40 mM Hepes, 150 mM KCl, 5 mM 
MgCl2 and 0.5 mM DTT (at pH 7.5) was loaded onto column before operating the 
proteins. Subsequently, the proteins were incubated together in 3 different 
conditions; at 8
0
C and 37 
0
C for 45 minutes and with 10 mM CaCl2 supply at 37 
0
C 
for 45 minutes. Incubated protein mix samples were applied to the same column with 
0.5 ml/min flow rate. To determine molecular weight of possible interaction or 
28 
 
oligomeric states, Bio-Rad Gel Filtration Standard
R
 was subjected to the tool, 
independently. 
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3. RESULTS 
The first aim of this thesis was to construct a plasmid in which Grp94 from Canis 
lupus familiaris is flanked by truncated Gorilla gorilla ubiquitin on the N- and C-
terminal site.  This led to a construct which will be referred to as Ubi-Grp94-Ubi. 
Ubi-Grp94-Ubi and wild-type (wt) Grp94 were then recombinantly expressed in 
E.coli and purified to assess the ATPase activity of both proteins. Km value 
corresponding affinity of Ubi-Grp94-Ubi against ATP has been evaluated to be 
compared with previous work results (Frey et al., 2007). Additionally, ATP 
measurement was conducted with the potential Grp94 co-chaperone pERp1/MZB1 in 
order to reveal its possible influence on Grp94 ATPas kinetics. Steady state ATPase 
activities in respect of titration of pERp1 has been calculated and fit to the single 
exponential equation, aiming to determine EC50. Apart from steady state kinetic 
measurement, pERp1, Ubi-Grp94-Ubi and combination of them were subjected to 
citrate synthase (CS) aggregation assay. Finally, the analytical size exclusion was 
operated to show interaction of pERp1 and Ubi-Grp94-Ubi and the oligomerization 
state of pERp1 in physiological conditions.  
3.1 Grp94 is subcloned into pET-28a to construct Ubi-Grp94-Ubi   
In order to produce the Ubi-Grp94-Ubi construct Grp94 PCR product was cloned 
into pET-28a vector with an Ubi-Hsp82-Ubi insert. The vector was double-digested 
with SacI and HindIII restriction enzymes. In used vector, both downstream of the 
HindIII restriction site and upstream of the SacI restriction site the same truncated 
ubiquitin tag is present. Hsp82 (which in the original construct had been cloned 
between the two ubiquitin tags) was cleaved out and gel purification was performed 
to get a digested pET-28a vector including the ubiquitin tags. The PCR of wt Grp94 
was performed by using a pET-21a vector by primers compatible for sequence and 
ligation independent cloning (Jeong et al., 2012). Subsequently, the one step ligation- 
independent cloning (SLIC) protocol was carried out by using the cleaved pET-28a 
vector and the Grp94 PCR product.  The reaction mixture was transformed into 
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competent XL-1 Blue strain. Insertion of wt Grp94 into pET-28a  was confirmed by 
sequencing.  
a) 1 kb DNA Marker    b)   Marker   Grp94 PCR Product     c) Marker       U      C      U      C      U      C 
            
 
Figure 3.1 :  Cloning of Ubi-Grp94-Ubi into the pET-28a vector. a) Peqlab 1 kb DNA 
Ladder
R
. b) The Grp94 PCR product aimed to be cloned into a pET-28a 
vector. c) Hsp82 was cleaved out from the pET-28a vector including Ubi-
Hsp82-Ubi sequence by double digestion with SacI and HindIII to produce a 
vector for Ubi-Grp94-Ubi cloning. C devotes cleaved and U devotes 
uncleaved pET-28a.  After the cleavege, the ubiquitin tags still were present 
on the vector. The percentage of agarose gel is 1%.  
 
3.2 Induction and Purification of Grp94 Constructs 
 
Both the wt Grp94 and the Ubi-Grp94-Ubi constructs were expressed in BL21 DE3-
CodonPlus™-RIL strain. 4 L of both strains in LB medium were grown until OD 
reaches 0.8 and protein expression was subsequently induced with 1 mM IPTG. 
After induction, the cells were incubated at 37 C
o
 for 3 hours. To purifiy wt Grp94, Q 
Sepharose
R
 column was used as a first anion-exchange step. Later, all elution 
fractions were used in second anion-exchange step, Resource
TM
 Q. As a final 
purification step, size exclusion (SEC) chromatography was applied to improve the 
purity. Since the C-terminal ubiquitin-tag in the Ubi-Grp94-Ubi construct includes a 
6His-tag, a HisTrap
TM
 FF column was operated in the first step of Ubi-Grp94-Ubi 
protein purification. Thereafter, Resource
TM
 Q anion-exchange and SEC were 
performed, respectively. The purity levels of Grp94 and Ubi-Grp94 were different, 
Ni-NTA affinity chromatography seems to be an influential step in Ubi-Grp94-Ubi 
purification, and led to a better purify of Ubi-Grp94 compared to wt Grp94.  10% 
SDS-gels of the proteins are depicted in Figure 3.2 and Figure 3.3.  
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Figure 3.2 :  SDS-PAGE analysis  of the purification steps of wt Grp94. a) Protein 
expression analysis with total  cell lysate: -I lane indicates the cell lysate 
before induction with 1 mM IPTG whereas +I shows the lysate after 
induction. b) Fractions of the Resource
TM
 Q anion-exchange purification step: 
The E1, E2, E3, E4, E5, E6 and E7 fractions were pooled  and used in SEC. 
c) Fractions of size exclusion chromatography: The protein fractions in lanes 
3, 4, 5 and 6 were pooled and used in further experiments.   
On basis of the quantity of purified proteins and their similar induction profiles,  it 
seems recovery of wt Grp94 is relatively higher than Ubi-Grp94-Ubi construct even 
there is a clear altitude of Ubi-Grp94-Ubi in purity (See figure 3.2 and 3.3 for SDS-
PAGE analysis of respective protein’s final purification extent). After sequential 
purification steps were fully completed for the constructs, the final amount has been 
evaluated  approximately 17 mg for wt Grp94 whereas it was only about 6 mg for 
ubiquitin-tagged construct. 
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Figure 3.3 :  SDS-PAGE analysis of the purification steps of Ubi-Grp94-Ubi. a)  Protein 
expression analysis with total cell lysates: -I  lane  shows the lysate before 
induction. +I lanes  depict the lysate after induction. b) Fractions of 
HisTrap
FF
 affinity chromatography: E1, E2 and E3 elution fractions were 
pooled to be used in next step (FT devotes ‘flowthrough fractions’). c) 
Fractions of the  Resource
TM
 Q anion-exchange purification step: E1, E2, E3, 
E4, E5 and E6 fractions  were pooled to be used in SEC. d) Fractions of size 
exclusion chromatography: All fractions were pooled to be used in further 
experiments. e) Final purification samples in respect of increasing amount of 
load. 
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3.3 Induction and Purification of pERp1 
pERp1 induction and purification successfully performed by using growth and 
purification protocols described in method sections 2.2.3 and 2.2.6. Respective gels 
below show gradual improvement in purification (Figure 3.4). 
 a)             INDUCTION                            b)      HISTRAP
FF
 ELUTION                                                            
         
c)      RESOURCE Q
TM
 ELUTION       d)                     SEC (75 pg)    
         
Figure 3.4 :  SDS-PAGE analysis of the induction and purification steps of pERp1 before 
TEV cleavage. a)  Protein expression analysis with total cell lysates: -I  lanes  
are correspond to the lysate samples before induction. +I lanes  are 
correspond to the lysate samples after induction. b) Fractions of HisTrap
FF
 
affinity chromatography: E1 to E8 elution fractions were pooled to be used in 
next step. c) Fractions of the  Resource
TM
 Q anion-exchange purification step: 
E1 to E13 fractions  were pooled to be used in SEC. d ) Fractions of size 
exclusion chromatography: The fractions in lanes 1 to 10 were pooled to be 
conducted to TEV enzymatic cleavage. 
 
                  
    M    __FT__   1    2    3    4   5    6    7    8     9    10 
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      a)                                     TEV CLEAVAGE   
 
                    
 
     b) HISTRAP
FF
 WASHING (FT)         c)            HISTRAP
FF
 ELUTION 
           
Figure 3.5 :  SDS-PAGE analysis of the TEV cleavage and second HisTrap
FF
. a)  TEV 
cleavage reaction: After (A) and before (B) incubation with His-tag 
containing TEV protease. b) Washing phase fractions of HisTrap
FF
 : The 
pERp1 was collected from flowthrough since after TEV cleavage pERp1 
does not include His-Tag. c) Fractions of the  HisTrap
FF 
elution phase: Both 
TRX-Tag and TEV protease eluted from E1 to E6 fractions.  
 
21 kDa pERp1 was seperated from TRX-Tag after 3 different purification steps were 
oparated by HisTrap
FF
, Resource Q
TM
 and HiLoad Superdex 75 PG, respectively. 
After the cleavage reaction, both used TEV protease and TRX-Tag were polished off 
by additional process of HisTrap
FF
 chromatography, and pERp1 was collected from 
flowthrough whereas the used TEV protease and TRX-tag was eluted by immidazole 
containing Tris Buffer B. 
          M                  B              A 
        M    ____________FT___________         M    ______FT______            E1    E2   E3    E4     E5      E6 
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3.4 Ubi-Grp94-Ubi Construct has slightly decreased Kcat 
The Kcat values of both proteins were determined by using a coupled ATPase assay. 
The mean Kcat value for wt Grp94  was around 0.037 min
-1 
and Ubi-Grp94-Ubi 
exerts its ATPase activity as much as wt Grp94 does, with slight decrease, 0.034 min
-
1
 at 30
0
C. Standart devition collected from 3 independent measurements for both 
protein is in acceptable range. 
     
Figure 3.6 :  Kcat values of wt Grp94  and Ubi-Grp94-Ubi  constructs at 30 
0
C.  The results 
are the mean of three measurements. The error bars indicate the standard 
deviations  and red bars convey mean of Kcat collected from 3  independent 
measurements.  
 
To determine a Michaelis Menten constant, Km correspond to the substrate 
concentration by which the reaction rate is half of Vmax, steady state kinetics 
examined with diffent concentrations of ATP at 37 
0
C. The plot was fit by using 
Michaelis Menten regression equation with the output of high r square. Interestingly, 
Km is calculated as 185 μM which strikingly differs the value of wt Grp94 estimated 
in Frey’s article, 92 μM (Frey et al., 2007). Additionaly, Vmax of Ubi-Grp94-Ubi at 
37 
0C is calculated as ‘0.0479 min-1’ according to Michelis Menten equation. It can 
be interpreted as that ubiquitin tag influences affinity of ATP to Grp94. This might 
be resulted from disruption of binding pocket positioned in N-terminal domain by 
ubiquitin tag. 
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Figure 3.7 :  Km calculation of Ubi-Grp94-Ubi  construct at 37 
0
C:  The Kcat values in 
respect of different concentration of ATP are depicted as black dots in plot 
and fit by Michaelis Menten equation,  are the mean of three measurements. 
According to the plot, Km of Ubi-Grp94-Ubi is calculated as 185 μM. 
 
3.5 pERp1/MZB1 stimulates ATPase Activity of the Constructs 
ATPase assay of Grp94 and Ubi-Grp94-Ubi were conducted with the  potential 
Grp94 co-chaperone pERp1/MZB1.  Significant change in Kcat was observed, 
approximately 2 fold increase for each construct in the presence of equalar molar of 
pERp1 (pERp1 conducted wt Grp94 is about 0.081 min
-1
 and 0.079 min
-1
). Ubi-
Grp94-Ubi  It should be noted that, first phase of NADH
+
 decrease correspond to 
first 10 minutes is taken into account while the raw data was being processed since 
overall graph seems  an exponential decrease plot rather than linear. It may caused 
from increased dissociation constant of pERp1-Grp94 complex once the nucleotide 
was introduced to the buffer. In other words, in the absence ATP, pERp1-Grp94 
binding constant is possibly higher  than that of in the presence of ATP and 
nucleotide shifts the equlibrium towards to dissociation. Supporting this, previously, 
it has been reported by a co-immunoprecipitation experiments that MZB1-Grp94 
interaction is strongly regulated by nucleotide and ATP prevents binding of pERp1 
(Rosenbaum et al., 2014).  
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Figure 3.8 :  Kcat values of wt Grp94 and Ubi-Grp94-Ubi proteins in the presence of 
pERp1/MZB1 (Grp94/Ubi-Grp94-Ubi:pERp1, 1:1 molar ratio) at 30 
0
C
 
. The 
results are the mean of three measurements.  The error bars indicate the 
standard deviations.  
 
Half maximal effective concentration (EC50) was evaluated as 28 μM with Vmax as to 
be 19,3 fold of Kcat by titration of pERp1 into ATPase activity of Ubi-Grp94-Ubi. 
              
Figure 3.9 :  Calculation of
 
 EC50 by titration of pERp1 to 3 μM Ubi-Grp94-Ubi at 30 
0
C. 
The results are the mean of three measurements and data are fit by single 
exponantial equation. EC50 was evaluated as 28 μM with Vmax= 19,3 fold of 
the evaluated Kcat. 
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3.6 CD Measurements of Grp94 Construct 
Secondary structure characterizations of both wt Grp94 and Ubi-Grp94-Ubi were 
analysed by using circular dichroism spectroscopy. CD scans were far UV and 
signals gained from both construct differ significantly. CD scan of the wt Grp94 has 
two minimals corresponding to 208 nm and 222 nm whereas that of Ubi-Grp94-Ubi 
includes one corresponding to 222 nm. 
                
                  a) 
                  
                   b) 
                           
          Figure 3.10 : Far UV CD measurements of Ubi-Grp94-Ubi and wt Grp94. 
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3.7 pERp1/MZB1 stimulates Citrate Synthase Aggregation 
Together with activation of folded proteins, Hsp90 family interacts many cellular 
proteins in stress conditions such as high temperature in order to protect them to be 
misfolded or aggregated, which may result in toxicity for cell. Here, aggregation 
assay was performed by using a model substrate, ‘Citrate Synthase (CS)’ and the 
aggregation states have been monitored at 360 nm, 43 
0
C for each experiment, as 
described before with slight changes (Buchner et al., 1991). 
             
Figure 3.11 :  Citrate synthase aggregation assay with different components and their 
combination: 0. 3 µM CS was used for each experiment in 40 mM HEPES 
Buffer at pH 7.5. The buffer was conducted independently to 1 µM Ubi-
Grp94-Ubi (referred as to Grp94, red line), 5 µM pERp1 (blue) and 
combination of Ubi-Grp94-Ubi:pERp1 mix (yellow)  in 1:5 molar ratio and 
prewarmed. Later CS was added before collecting data. The graph was 
plotted in two dimension, time (min) and absorbance at 360 nm. ‘Only 
pERp1’ exerts the highest aggregation progression, significantly higher than 
‘only CS’ (black line). Grp94:pERp1 (1:5, yellow line) combination has      
no visible difference with only Ubi-Grp94-Ubi in CS aggregation 
measurements.  
 
The experiments were operated in the presence of only Ubi-Grp94-Ubi, only pERp1 
and both of protein, independently. Additionaly, the aggregation progress has been 
monitored in the presence of only citrate synthase as control. Interestingly, pERp1 
conducted citrate synthase shows significantly stimulated aggregation whereas Ubi-
Grp94-Ubi expectedly, supressed the aggregation progression. 
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3.8 Analytical Gel Filtration Assay 
Early on, binding of pERp1 to Grp94 has been shown with co-IP experiments 
(Rosenbaum et al., 2014). Here, it was aimed to reveal the interaction by another 
technique, analytical gel filtration which would be validation of pre-identified 
pERp1-Grp94 complex. Gel filtration column in line with HPLC system is versatile 
and practical tool to detect protein-protein interaction including oligomerization 
states of certain proteins. In our experiments, respective proteins were conducted 
onto Superdex 200 10/300 GL, which 3 different conditions priorly were applied 
independently. 
     
Figure 3.12 :  Analytical size exclusion chromatograms of individual proteins Ubi-Grp94-
Ubi, pERp1 and their combination. 
Hereby, pERp1 and Ubi-Grp94-Ubi complex has not been shown by the analytical 
size exclusion chromatography (Figure 3.12). However, interestingly, a slight 
shoulder peak before main peak of pERp1, correspond to higher molecular weight 
than that of pERp1 has been observed on pERp1 chromatograph. This might be 
caused from dimeric form of pERp1.  
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4. DISCUSSION 
The molecular chaperone Hsp90 is an essential eukaryotic protein which assists the 
final maturation of a set of client proteins.  Unlike other chaperone families, the 
clients of Hsp90 have no defined motif that mediates interaction with the chaperone 
and interestingly, comprise diverse classes of proteins which are structurally 
unrelated. Hsp90 functions in an ATP-dependent fashion and undergoes 
conformational changes in which the states are energetically similar (Röhl et al., 
2013). In the apo-form, Hsp90 adopts an open conformation whereas ATP binding 
induces a closed conformation. ATP binding leads to N- domain dimerization and it 
is followed by a contact of the M domain with the nucleotide- binding pocket of N 
domain (Ali et al., 2006). These conformational changes result in ATP hydrolysis 
with close proximity of the putative catalytic residue in M domain to the ATP in 
nucleotide binding pocket. The ADP-bound Hsp90 shows a highly compact state 
distinct from the closed AMP-PNP-bound state (Huai et al., 2005; Shiau et al., 2006). 
It should be noted that due to highly dynamic nature of Hsp90, nucleotide binding to 
Hsp90 slightly shifts the conformational equilibrium towards a closed state rather 
than dictating a certain conformation (Southworth et al., 2008; Krukenberg et al., 
2009; Mickler et al., 2009). However, an EM study has demonstrated that all three 
conformations are conserved among cytosolic yeast, human and prokaryotic Hsp90s 
(Southworth et al., 2008). In this study, both Hsc82 from yeast and human Hsp90α 
were shown to adopt a closed state upon addition of a non-hydrolyzable ATP 
analogue, AMP-PNP and a more compact state by incubation with ADP. It is 
noteworthy that Grp94 resembles human Hsp90 referred as to ‘Hsp90α’ in 
magnitude of shift upon addition of ATP, which is less than that of Hsp82, its yeast 
cytosolic counterpart (Southworth et al., 2008).  
Hsp90 is not alone to deal with diverse clients, but cooperates with a set of co-
chaperone, which serve as client recruiters or function in remodelling of Hsp90 itself 
(Röhl et al., 2013). In the course of evolution, particularly for eukaryotes, the 
coordination with a set of accessory proteins is an expected adaptation of Hsp90 in 
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order to function as a chaperone interacting with structurally unrelated substrates. 
The diversity in co-chaperones  allows Hsp90 interaction with specific clients, the 
stabilization of a certain conformation and the maturation of substrates or the 
recruitment of clients from Hsp70 (Lee et al., 2012; Schmid et al., 2012; Southworth 
et al., 2011; Roe et al., 2004). Therefore, the nature of the synergism between Hsp90 
and its co-chaperones is at the center of current studies to elucidate the mechanistic, 
dynamic and functional properties of Hsp90. Here, in the context of this thesis, initial 
steps have been taken to elicit whether the endoplasmic reticulum paralog of Hsp90, 
Grp94 differs from its counterparts in terms of its ATPase kinetics. In the first part of 
the work, the ATPase activity of wt Grp94 and an N- and C-terminally ubiquitin-
tagged Grp94 construct were determined and compared with each other. The Kcat 
value of wt Grp94 was determined 0.037 min
-1
 at 30 
0
C. Similarly, Ubi-Grp94-Ubi 
exerts 0.034 min
-1
, slightly decreased compared to wt Grp94. One must be point out 
that Grp94 had long been conceived to have no  intrinsic ATPase activity until a 
structural and a kinetic study  independently demonstrated this (Dollins et al., 2007; 
Frey et al., 2007). Since the crystal structure of AMP-PNP-bound Grp94 revealed 
that the conserved catalytic residue R448 is far from the nucleotide binding pocket, it 
had been hypothesised that ATP hydrolysis is driven by either an unidentified co-
chaperone or a client, but not the conformational change following ATP binding in 
cytoplasmic Hsp90. Importantly the two studies presented substantially different Kcat 
values, approximately 0.36 min
-1
 in Frey’s study compared to a Kcat of 0.02 min
-1
 in 
Dollins’ article which is more likely in line with our measurement. It should be 
considered that differences in the extent to which Grp94 was purified in the different 
studies might have led to deviations in the ATPase rate result in two different Kcat 
values. One may bear in mind that one or more E. coli protein contaminants present 
in purified Grp94 in Frey’s study might have acted as accessory protein that 
influences the ATPase rate. This speculation is important, as mentioned above ATP 
binding itself might not be able to drive Grp94 N-terminal dimerization between 
protomers. Because it is known that E. coli proteome contains a set of 
immunoglobulin folding proteins (Bodelon et al., 2012) and an unidentified 
accessory contaminating native protein of host cell might interfere with the ATPase 
activity. Another reason behind this conflict between ATPase rates of these two 
different papers might have resulted from the N-terminal His-tag used in the Dollins 
paper, which may interrupt the ATPase cycle or binding of NECA.  
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However, the Dollins paper is in line with the data in this thesis, where not N-
terminal His-tag was present and the Ubi-Grp94-Ubi construct exerts similar ATPase 
activity compared to wt Grp94. Therefore, rather than introduced tag into the Grp94, 
purification level must be the primary suspicious in deviation between our data and 
Frey’s result.  
In the second part of this work, the ATPase activity assay was conducted in 
combination with the potential Grp94 co-chaperone MZB1 which is also known as 
pERp1. pERp1 first has been identified by two independent studies. It is implicated 
in B cell differentiation, IgM biosynthesis and secretion (Shimizu et al., 2008; Anken 
et al., 2009). The question if Grp94 has any co-chaperones has not yet been clarified 
but there are some indications that Grp94 co-chaperones exist. A recent study has 
revealed that pERp1 knock-down in mouse leads to an impairment in antibody 
secretion and B-cell differentiation. The same study also stated that under ER stress 
conditions, pERp1 is required for the interaction of Grp94 with the immunoglobulin 
m heavy chain (Rosenbaum et al., 2014).  Additionally, an earlier study pointed out 
that CNPY3 might be a presumptive Grp94 co-chaperone that is required for Toll-
like biosynthesis (Liu et al., 2010). Interestingly, pERp1 and CNPY3 share 
homology and their interaction with Grp94 is nucleotide sensitive (Rosenbaum et al., 
2014). Supporting this idea, CNPY3 study reported that mutation of a putative 
catalytic residue of Grp94, E103A resulted in loss of interaction significantly (Liu et 
al., 2010). A co-chaperone driven conformational shift of Grp94 has not been 
reported yet.  
In our study, pERp1 addition causes a significant increase with two fold over the 
basal ATPase activity whereas an earlier study showed no impact of pERp1 on the 
ATPase activity of wt Grp94 (Rosenbaum et al., 2014). In this paper unlike in this 
thesis, geldanamycin was used as ATPase inhibitor to assess the background ATPase 
activity (i.e., the ATPase activity of contaminant proteins). One reason that my 
results differ from the previous study might thus be that geldanamycin is not as 
effective as NECA the specific inhibitor of Grp94, which was used in my thesis. The 
affinity or binding kinetics of the two inhibitors may differ from each other in the 
presence of pERp1 and we have no insight yet on the 3-D architecture of the pERp1-
Grp94 interaction. Concerning this thesis, it must be pointed out that the initial 10 
minutes is taken into account to calculate Kcat values in titration of pERp1. The 
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reason behind to prefer the first minutes in calculation is that the NADH oxidation 
pattern monitored during assay was more likely a single exponential decrease rather 
than linear. Linear plot is gradually turn into single exponential curve with increasing 
pERp1 concentration, is presumably consequence of pre-identified nucleotide 
regulated binding (Rosenbaum et al., 2014). 
Regarding affinity of pERp1 and Grp94 interaction, one may bear in mind that our 
EC50 can be expected to be in good line with the dissociation constant which would 
be obtained from either ITC or CD. Surely, ATP has been shown to regulate binding; 
it must increase Kd and similarly, our raw ATPase activity data by time fits single 
exponential equation can be interpreted as effect of increasing binding constant 
between pERp1 and Grp94 upon addition of ATP. Therefore, EC50 must be higher 
than any Kd value which can be calculated by different approach in the absence of 
ATP, but rather low than that of in the presence of ATP.  
Even though, it seems to be early to set a scenario concerning pERp1 regulated 
ATPase activity of Gpr94, pERp1 conducted steady state kinetic data shows 
significant increase in activity, can be clue of conformational re-arrangements which 
makes ATP hydrolysis favourable. It may be caused from relatively close proximity 
of R448, putative catalytic residue which is positioned in M domain upon interaction 
with pERp1. From different aspect, pERp1- bound Grp94 might be adopted to an 
unique conformation which cause less energetic burden for transition to catalytically 
active, N-terminally dimerized conformation by disturbing acquired twisted V 
conformation. Presumably, pERp1 navigates Grp94 to adopt conformationally more 
favourable state to hydrolyse ATP, before loading of nucleotide binding pocket with 
ATP. However, to clarify the structural basis of increased ATPase activity we need 
to refer structural techniques such as co-crystallization or NMR. Morever, ATP 
binding kinetics of pERp1-Grp94 should be calculated to reveal if the increased 
ATPase activity is resulted from higher affinity to ATP. However, this scenario 
seems less possible since Grp94 has relatively stronger binding affinity to ATP 
compared to other Hsp90s (Frey et al., 2007). Intriguingly, what might be the 
physiological relevance of the stimulated ATPase activity in immunoglobin 
maturation? Is pERp1 creating only an interaction platform for immunoglobin and if 
exists, in which aspects it regulates ATPase activity to demand its maturation? How 
the domain organisation re-arranged by pERp1 in respect to orientation at interfaces 
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between N-M and M-C? These are main questions which must be addressed as future 
aspect.  
It has been earlier stated that pERp1 may be an unique chaperone for IgM monomers 
since pERp1 is still capable of binding to the monomers in the presence of DTT 
highlighting the binding does not primarily depends on cysteine cross-links (Anken 
et al., 2009). In our study, CS aggregation assay is operated to show chaperone 
activity of Grp94 and any possible effect of pERp1 on progression of the thermal 
aggregation. Interestingly, pERp1 remarkably stimulated to CS aggregation in our 
study. This may be caused from oxidoreductase activity of pERp1, leading CS to be 
more prone to be aggregated due to reduction of native disulfide bonds. Scrambled 
species with non-native disulfide bonds might be propagated and consequently 
contributed to thermal aggregation. Another possibility is that it might be an artefact 
which is resulted from high molar usage of pERp1 (5 μM).  
In conclusion, our data indicate that pERp1 impacts the ATPase activity and exhibits 
moderate binding constant regarding the interaction with Grp94. However, the 
mechanism of pERp1 interaction with Grp94 is still in its infant phase. An intriguing 
question to be addressed in the future is whether the interaction of pERp1 affects the 
conformational equilibrium of Grp94 in solution. Dissecting a possible regulation of 
Grp94 by a potential co-chaperone would not only facilitate elucidating the gear of 
Grp94’s molecular mechanism but also give first insights of immunoglobin 
maturation basis. 
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APPENDIX A 
Äkta FPLC machine Amersham, Uppsala, Sweden 
Amicon Ultra 4 mL centrifugal filter Merck, Darmstadt, Germany 
Amicon Ultra 15 mL centrifugal filter Merck, Darmstadt, Germany 
Avanti J 25 centrifuge Beckman, Wien, Austria 
Balance BP 121 S S Sartorius, Göttingen, Germany 
Balance BL 310 Sartorius, Göttingen, Germany 
Cell disruption machine Basic Z Constant Systems, Warwick, England 
Certomat S Shaker Braun Biotech, Melsungen, Germany 
DEAE Sephacel GE Healthcare, Freiburg, Germany 
Dialysis membrane Spectrum, Houston, USA 
Eppendorf 5415 C centrifuge Eppendorf, Hamburg, Germany 
Eppendorf thermomixer Eppendorf, Hamburg, Germany 
GradiFrac system Amersham, Uppsala, Sweden 
Hoefer Mighty Small II gel electrophoresis Amersham, Uppsala, Sweden 
HPLC PU-1850, UV-1575 Jasco, Gross-Umstadt, Germany 
Ice machine Ziegra, Isernhagen, Germany 
Jasco J715 Jasco, Groß-Umstadt, Germany 
LKB GPS 200/400 voltage source Amersham, Uppsala, Sweden 
Magnetic Stirrers MR 2000 Heidolph, Kelheim, Germany 
Ni-NTA HisTrap
FF 
GE Healthcare, Freiburg, Germany 
pH-meter WTW, Weilheim, Germany 
Primus Thermocycler MWG, Ebersberg, Germany 
Resource Q 6 ml GE Healthcare, Freiburg, Germany 
Sonifier B-12 Branson, Danbury, USA 
HiLoad Superdex 75 PG GE Healthcare, Freiburg, Germany 
HiLoad Superdex 200 PG  GE Healthcare, Freiburg, Germany 
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Superdex 200 PG 10/300 GL GE Healthcare, Freiburg, Germany 
Varian Cary 50 UV-Vis spectrophotometer Varian, Palo Alto, USA 
Varioklav steam autoclave EP-Z H+P, Oberschleißheim, Germany 
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APPENDIX B 
Acrylamide (38:2% Bisacrylamide) Roth, Karlsruhe, Germany 
Adenosin‐5´‐triphosphate disodium salt Roche, Mannheim, Germany 
Agarose powder Roche, Mannheim, Germany 
Ammoniumperoxodisulfate (APS) Roche, Mannheim, Germany 
Ampicillin Roth, Karlsruhe, Germany 
Alexa Fluor 488 maleimide Invitrogen, Carlsbad, USA 
Bromphenol blue S Serva, Heidelberg, Germany 
Calcium chloride  Merck, Darmstadt, Germany 
Coomassie Brilliant Blue G‐250 Serva, Heidelberg, Germany 
Dithiothreitol (DTT) Roth, Karlsruhe, Germany 
Ethanol Roth, Karlsruhe, Germany 
Ethidiumbromide Sigma, St. Louis, USA 
HEPES Sigma, St. Louis, USA 
Hind III HF New England Biolabs, Germany 
Kanamycin Roth, Karlsruhe, Germany 
Lactate dehydrogenase (LDH) Roche, Mannheim, Germany 
Magnesium chloride hexahydrate Merck, Darmstadt, Germany 
Nicotinamide adenine dinucleotide Roche, Mannheim, Germany 
N,N,N',N'‐Tetramethylethylendiamin  Roth, Karlsruhe, Germany 
Imidazole Sigma, St. Louis, USA 
Isopropylβ‐D‐1‐thiogalactopyranoside Merck, Darmstadt, Germany 
Pfu DNA polymerase Promega, Madison, USA 
Phosphoenolpyruvate (PEP) Roche, Mannheim, Germany 
Potassium chloride Merck, Darmstadt, Germany 
Protease inhibitor mix G Serva, Heidelberg, Germany 
Protease inhibitor mix HP Serva, Heidelberg, Germany 
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Pyruvate kinase (PK) Roche, Mannheim, Germany 
SacI HF New England Biolabs, Germany 
Sodium chloride Merck, Darmstadt, Germany 
Sodium dihydrogen phosphate dehydrate Merck, Darmstadt, Germany 
Sodiumdodecylsulfate (SDS) Roth, Karlsruhe, Germany 
Tris‐(hydroxymethyl)‐aminomethan (TRIS) ICN, Irvine, USA 
5'-N-ethylcarboxamidoadenosine Sigma, St. Louis, USA 
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APPENDIX C 
 
15% Separation gel : 3.75 mL 40% Acrylamide (Acryl./Bisacryl. 38:2)  
                                     2.50 mL 4x SDS-Buffer (0.8% SDS, 1.5 M Tris, pH 8.8)  
                          3.75 mL dH2O  
10% Separation gel : 2.50 mL 40% Acrylamide (Acryl./Bisacryl. 38:2)  
                                  2.50 mL 4x SDS-Buffer (0.8% SDS, 1.5 M Tris, pH 8.8)  
                                  5.00 mL  dH2O  
5%  Stacking gel :        0.625 mL  40% Acrylamide (Acryl./Bisacryl. 38:2)  
                                    2.50 mL 2x SDS-Buffer (0.4% SDS, 0.3 M Tris, pH 6.8)  
                                  1.875 mL dH2O 
 
TAE (50x) : 2 M Tris/acetate pH 8.0, 50 mM EDTA pH 8.0 
 
SDS running buffer (10x) : 250 mM Tris/HCl pH 6.8 2 M Glycine 1% (w/v) SDS 
 
SDS running buffer (10x) : 250 mM Tris/HCl pH 6.8 2 M Glycine 1% (w/v) SDS 
 
SDS sample buffer (5x) : 312.5 mM Tris/HCl pH 6.8,10% (w/v) SDS 50% (v/v) 
Glycerol 2.5% (v/v) β-mercaptoethanol 0.05% (w/v) bromphenolblue 
 
Fairbanks A : 2.5 g Coomassie Brilliant Blue R-250, 250 mL Ethanol, 80 mL 
Acetic acid adjusted to 1 L with H2O 
 
Fairbanks D : 250 mL Ethanol, 80 mL Acetic acid, 670 ml H2O 
Buffer A : 40 mM HEPES, 50 mM KCl, and 10 mM CaCl2, pH 7.5, 1 mM DTT. 
Buffer B : 40 mM HEPES, 0.5 M KCl, and 10 mM CaCl2, pH 7.5, 1 mM DTT. 
Buffer C : 40 mM HEPES, 0.5 M KCl, and 5 mM MgCl2, pH 7.5, 1 mM DTT. 
Phosphate Buffer A : 20 mM NaH2PO4, 500 mM NaCl, 20 mM imidazole, pH 7.5. 
Phosphate Buffer B : 20 mM NaH2PO4, 500 mM NaCl, 500 mM imidazole, pH 7.5. 
 
Tris Buffer A : 50 mM TRIS, 50 mM NaCl, pH 7.5, 0.5 mM DTT. 
 
Tris Buffer B : 50 mM TRIS, 500 mM NaCl, pH 7.5, 0.5 mM DTT. 
 
 
60 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
61 
 
 
CURRICULUM VITAE 
 
 
 
 
 
Name Surname  : Mustafa Barbaros DÜZGÜN 
Place and Date of Birth : Çanakkale/ TURKEY,  24.05.1989 
E-Mail     : barbarosduzgun@gmail.com 
B.Sc.       : Istanbul Technical University 
M.Sc.      : Istanbul Technical University 
 
Professional Experience and Rewards : 
 2010 (3 months) Summer Internship at Senatoryum Hospital: Immunostaining 
techniques and microscopy of lung tissue have been operated with the assistance 
of the section officials. 
 2011-2013 Student Researcher at Dinler Lab: The project was based on 
mutational study regarding nucleotide bining domain of E.coli Hsp70, DnaK, by 
which allosteric mechanism playing central role in interplay between the two 
domains was aimed to be elucidated with residual basis. 
 2014 (4 months) Student Researcher at Karagüler Lab: The study focused on 
efficient expression and purification of E.coli Aquaporin protein to be analyzed 
and utilized in developing a water purification system within aspects of 
biotechnology. 
 2014-2015 (1 year) Erasmus Exchange Programme Scholarship: This master 
thesis has been performed by aid of financial support provided in the context of 
Erasmus  Exchange Programme. 
 2014-2015 (9 month) Master Thesis Project at Buchner Lab 
 2014-2015 (3 month) Student Assistantship (Studentische Hilfskraft) at 
Weinkauf Lab: The main purpose of the participated study was disclosing 
structural basis of oligomeric behaviour of alpha-ctystallin which is a member of 
small heat-shock proteins. The basics of single particle analysis of EM 
techniques have been partly acquired during the part-time job. 
 
 
 
 
 
62 
 
 
 
 
